Skip to main content

Table 2 Results for nine cases of ischemic central retinal vein occlusion

From: Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

Finding

Baseline

6 months

p value

Visual acuity, logMAR

1.3 (1 to HM)

1.7 (1.3 to NLP)

0.02*

Central foveal thickness

858 ± 311

243 ± 106

0.0006#

Central choroidal thickness

282 ± 38

227 ± 56

0.0003#

  1. Data are presented as median (range) or mean ± standard deviation
  2. HM hand movements, NLP no light perception
  3. *Wilcoxon signed-rank test
  4. #Pairwise t-test
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us